Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-17,177
Closed -$175K 8582
2025
Q2
$169K Sell
17,177
-14,602
-46% -$121K ﹤0.01% 4505
2025
Q1
$231K Sell
31,779
-50,440
-61% -$441K ﹤0.01% 3865
2024
Q4
$643K Buy
82,219
+68,732
+510% +$566K ﹤0.01% 2967
2024
Q3
$99.8K Sell
13,487
-27,745
-67% -$233K ﹤0.01% 4175
2024
Q2
$330K Buy
41,232
+29,269
+245% +$261K ﹤0.01% 2946
2024
Q1
$139K Sell
11,963
-5,895
-33% -$65.3K ﹤0.01% 3850
2023
Q4
$199K Sell
17,858
-70,187
-80% -$645K ﹤0.01% 3865
2023
Q3
$1.36M Buy
88,045
+79,185
+894% +$1.33M ﹤0.01% 1979
2023
Q2
$168K Buy
8,860
+244
+3% +$4.29K ﹤0.01% 4122
2023
Q1
$131K Sell
8,616
-1,225
-12% -$16K ﹤0.01% 4047
2022
Q4
$125K Buy
9,841
+9,441
+2,360% +$84.9K ﹤0.01% 4234
2022
Q3
$2K Buy
+400
New +$1.76K ﹤0.01% 7139

Other funds holding ETNB

Group One Trading's ETNB Position: Q3 2025 in Review

Group One Trading sold out of 89bio (ETNB) in Q3 2025, closing a stake of 17,177 shares — an estimated $175K sold.

Group One Trading first reported a position in ETNB in Q3 2022 and held it in 12 quarters. The position peaked at $1.36M in Q3 2023. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

  • Group One Trading reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 17,177 89bio shares in Q3 2025, an estimated $175K.
  • Group One Trading first reported a position in 89bio in Q3 2022 and held it in 12 quarters.
  • Group One Trading's 89bio position peaked at $1.36M in Q3 2023.
  • 198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.